A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver.
about
The Natural Course of Non-Alcoholic Fatty Liver DiseaseNAFLD and Increased Aortic Stiffness: Parallel or Common Physiopathological Mechanisms?Treatment of patients with type 2 diabetes and non-alcoholic fatty liver disease: current approaches and future directionsType 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection--Liver: The "Musketeer" in the SpotlightExtracellular Vesicles: A New Frontier in Biomarker Discovery for Non-Alcoholic Fatty Liver DiseaseNonalcoholic Fatty Liver Disease: Pros and Cons of Histologic Systems of EvaluationLiver fibrosis in non-alcoholic fatty liver disease - diagnostic challenge with prognostic significance.Obesity: physiologic changes and implications for preoperative managementHepatocellular carcinoma in patients with non-alcoholic fatty liver diseaseDefinitions of Normal Liver Fat and the Association of Insulin Sensitivity with Acquired and Genetic NAFLD-A Systematic ReviewMolecular Pathogenesis of NASHA Review of Western and Traditional Chinese Medical Approaches to Managing Nonalcoholic Fatty Liver Disease.Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIVSirtuins and nonalcoholic fatty liver diseaseRecommendations for Diagnosis, Referral for Liver Biopsy, and Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic SteatohepatitisNon-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE.Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease.Controversies in the Diagnosis and Management of NAFLD and NASH.A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis.Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis.Green tea polyphenols ameliorate non-alcoholic fatty liver disease through upregulating AMPK activation in high fat fed Zucker fatty ratsNon-alcoholic fatty liver disease: An expanded reviewInhibition of NLRP3 inflammasome by thioredoxin-interacting protein in mouse Kupffer cells as a regulatory mechanism for non-alcoholic fatty liver disease developmentSystems biology approaches for studying the pathogenesis of non-alcoholic fatty liver disease.External validation of fatty liver index for identifying ultrasonographic fatty liver in a large-scale cross-sectional study in Taiwan.Physiology and pathophysiology of liver lipid metabolism.Prognostic Value of Non-Invasive Fibrosis and Steatosis Tools, Hepatic Venous Pressure Gradient (HVPG) and Histology in Nonalcoholic SteatohepatitisPlasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease.Nutrigenomics analysis reveals that copper deficiency and dietary sucrose up-regulate inflammation, fibrosis and lipogenic pathways in a mature rat model of nonalcoholic fatty liver diseaseRenin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression: An Observational Study in Patients with Nonalcoholic Fatty Liver DiseaseAnalysis of association between circulating miR-122 and histopathological features of nonalcoholic fatty liver disease in patients free of hepatocellular carcinoma.Characterisation of liver fat in the UK Biobank cohort.Osteopontin is a proximal effector of leptin-mediated non-alcoholic steatohepatitis (NASH) fibrosis.The hepatic lipidome: a gateway to understanding the pathogenesis of alcohol-induced fatty liverPoor Inter-test Reliability Between CK18 Kits as a Biomarker of NASHIncreased Serum Levels of LIGHT/TNFSF14 in Nonalcoholic Fatty Liver Disease: Possible Role in Hepatic Inflammation.Histology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in Adults and Children.Nonalcoholic Fatty Liver Disease: Lipids and Insulin Resistance.Medical and Surgical Treatment Options for Nonalcoholic Steatohepatitis.Nonalcoholic fatty liver disease is associated with excessive calorie intake rather than a distinctive dietary pattern.
P2860
Q26746947-4157412C-3203-4F23-848A-2E7195378FD3Q26750955-11D3C0AC-F4CA-4FC7-B67E-FA1193E77CFDQ26751258-3078F673-AAC4-41C1-B82A-D5913B3D2957Q26752583-CC3A364E-F596-4A5C-A5D7-98D974A5DEC5Q26764843-F5718DED-5189-4791-9778-9D1E1ACE9B72Q26771722-9F26B773-39D8-4114-86C4-FB486EC7DD50Q26780252-66D44DC7-C0A1-4A9E-9214-708E453A24B2Q26830911-2E008CBF-C7B8-44D2-8FF5-C9C6509D1402Q28066100-18017F21-4B3E-4B02-A25B-EAF236CE0ACDQ28070408-F92C59D3-1CAD-4A39-B86D-D384F1579381Q28071265-3AE7BC68-BF1B-4933-9C0B-C12F6046FEDCQ28074377-9C407C31-4947-43C3-A3CD-FFE01A8461D3Q28079826-42237DBE-D429-40DE-9E75-9EC848156807Q28079953-17F0BD58-0C9B-4E4D-8119-C63F5F9C4F33Q28607750-9C1B10D5-6C12-4903-A244-14642B50AE31Q30366569-BD08F432-49C6-4B62-99E4-34C4F6060F08Q30389327-8427FA57-D395-425D-A8E0-EF4556EB9FEEQ30412296-0ADD0CE8-8A1E-4975-A423-F949CEA46706Q33574413-C44877A1-2AD5-4FF7-96C9-BB7EACB54AB4Q33639969-5650B303-1594-46DA-A864-A02591196FAFQ33786020-2E8060AA-85B0-4063-9CF2-CF931CCCC0D8Q33789868-350166B6-D569-466D-9EEF-6DCA07C02126Q33914071-F4811AB0-8EDC-4374-8EBF-73758AA5B87CQ34467142-264CDE1D-9EA3-4B8F-A3C8-34798EB51E4EQ35188136-A9817771-FA64-41D4-8FEC-F75AEA0F291BQ35662655-DF96AC72-F3F9-442B-A66C-96E132F8B0A8Q35666218-059BFB22-51D3-45C4-BA43-8F42CD36C341Q35965687-1044E632-9B7C-40AF-B623-1D87D31DD487Q36083434-F100E121-58F7-4B61-89DE-81FEEFCF7F4DQ36138443-8A61BB3C-F27D-4FFB-A9D0-11A4ACE54BF0Q36220756-8E160710-D8E4-448F-A89A-D655E4F24E40Q36291704-D9E1F2F6-C75F-4D62-AE78-7D6A6305B17EQ36588292-1688F1AD-E6E4-4E98-92CC-08D4796C85A4Q36590606-D24EBFE0-6ED9-4390-89ED-45CA884F1026Q36600213-8C661A63-A028-402C-BBEE-8EF4EF798E57Q36752011-A9C88650-D4F2-40B6-8615-2EAAEF861B30Q36791363-E8FE7E0A-6F9D-419C-A456-D893CBF3E8EDQ36796030-21BADB8C-29AE-4EFC-A543-7C23C75EADC2Q36818351-A00651AC-7DE6-4B3F-B582-C3A34C892FB8Q37003731-D640EA80-5BD3-434A-B0F7-7B532CBB2257
P2860
A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
A systematic review of follow- ...... ith non-alcoholic fatty liver.
@en
type
label
A systematic review of follow- ...... ith non-alcoholic fatty liver.
@en
prefLabel
A systematic review of follow- ...... ith non-alcoholic fatty liver.
@en
P2093
P1476
A systematic review of follow- ...... ith non-alcoholic fatty liver.
@en
P2093
Fréderic Charlotte
LIDO Study Group
Larissa Fedchuk
Pascal Lebray
Raluca Pais
Vlad Ratziu
P304
P356
10.1016/J.JHEP.2013.04.027
P577
2013-05-09T00:00:00Z